Abcam plc ABCM 0.00 Abcam plc

Home
⇒ 
Stock List ⇒ Abcam plc
Range:12.48-25.32Vol Avg:5816355Last Div:0Changes:0.01
Beta:0.86Cap:5.52BCurrency:USDExchange:NASDAQ
Sector:HealthcareIPO:Thu Oct 22 2020Empoloyees:1760
CUSIP:000380204CIK:0001492074ISIN:US0003802040Country:GB
CEO:Mr. Alan Thomas Hirzel BS, M.B.A., M.S.Website:https://www.abcam.com
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, miRNA kits, biochemicals, and cell signaling pathway tools. The company serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. It has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. The company sells its products online. Abcam plc was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.

Stock Details

The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
DMCA.com Protection StatusPowered by StackThrow